- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03203122
Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa
June 28, 2017 updated by: Zealand University Hospital
The Effect of Intense Pulsed Light Assisted Hair Removal Therapy on Mild and Moderate Cases of Hidrosadenitis Suppurativa
6 monthly treatments with IPL laser in patients with Hidradenitis Suppurativa.
The effect in measured on several severity scores.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patient suffering from bilateral HS in the axilla or groin area are threated with IPL laser monthly for 6 months.
Patients are randomized to treatment in either left or right side, the other side works as control.
No sham treatment, but observers are blinded.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Roskilde, Denmark, 4000
- Recruiting
- University hospital Zealland
-
Contact:
- Peter T Riis, MD
- Phone Number: 47322672
- Email: pmik@regionsjaelland.dk
-
Contact:
- Linnea Thorlacius, MD
- Phone Number: 47322671
- Email: lrit@regionsjaelland.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Bilateral HS in the axilla or groin area
- Fitzpatrick skin type I-II
Exclusion Criteria:
- Pregnant
- Unable to understand or communicate with study personnel
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
Patients are randomized to treatment of either right or left side.
The other side works as control
|
IPL laser monthly.
Vertical and horizontal treatment, one pass over.
Settings according to fitzpatrick skin type
|
Sham Comparator: Comparator Group
Patients are randomized to treatment in either right or left side.
The other side works as control
|
The treatment is slightly painful, and noisy.
Sham treatment impossible
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HiScore
Time Frame: After 6 treatments i.e. 6 months
|
50 % reduction in abcesses and draining fistual
|
After 6 treatments i.e. 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sartorius score
Time Frame: after 6 treatments i.e. 6 months
|
HS severity score
|
after 6 treatments i.e. 6 months
|
Physician global assesment
Time Frame: after 6 treatments i.e. 6 months
|
HS severity score
|
after 6 treatments i.e. 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 7, 2017
Primary Completion (Anticipated)
August 1, 2018
Study Completion (Anticipated)
August 1, 2019
Study Registration Dates
First Submitted
June 27, 2017
First Submitted That Met QC Criteria
June 28, 2017
First Posted (Actual)
June 29, 2017
Study Record Updates
Last Update Posted (Actual)
June 29, 2017
Last Update Submitted That Met QC Criteria
June 28, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REG-115-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Will not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hidradenitis Suppurativa
-
Yale UniversityNot yet recruitingHidradenitis Suppurativa | Hidradenitis Suppurativa, Acne Inversa | Hidradenitis Suppurativa \(HS\)United States
-
Incyte CorporationRecruitingHidradenitis Suppurativa (HS)United States, Canada, Czechia, Spain, Germany, Poland, Netherlands, Belgium, France, Greece, Japan, Austria
-
Boehringer IngelheimRecruiting
-
Incyte CorporationRecruitingHidradenitis Suppurativa (HS)United States, Canada, Bulgaria, Italy, Spain, Germany, Poland, France, Australia, Denmark, United Kingdom
-
Novartis PharmaceuticalsAvailableHidradenitis Suppurativa (HS)
-
AbbVie (prior sponsor, Abbott)CompletedHidradenitis Suppurativa (HS)
-
InflaRx GmbHQuintiles, Inc.CompletedHidradenitis Suppurativa (HS)United States, Bulgaria, Canada, Denmark, France, Germany, Greece, Netherlands, Poland
-
Erasmus Medical CenterNot yet recruitingHidradenitis Suppurativa, Acne Inversa
-
Incyte CorporationRecruitingHidradenitis Suppurativa (HS)United States, Austria, Belgium, Canada, Germany, Poland, Spain, Australia, Denmark, France, United Kingdom, Japan, Bulgaria, Netherlands, Czechia, Greece, Italy
-
Association pour la Recherche Clinique et ImmunologiqueNot yet recruitingHidradenitis Suppurativa (HS)France
Clinical Trials on IPL laser
-
Goldman, Butterwick, Fitzpatrick and GroffNot yet recruitingKeratosis Pilaris
-
NHS Greater Glasgow and ClydeUnknown
-
Leortec Medical Systems LtdCompleted
-
Zealand University HospitalUnknownHyperhidrosis Primary Focal AxillaDenmark
-
Aston UniversityRecruitingDry Eye Syndromes | Meibomian Gland DysfunctionUnited Kingdom
-
Second Affiliated Hospital, School of Medicine,...RecruitingErythematotelangiectatic RosaceaChina
-
First Affiliated Hospital of Harbin Medical UniversityCompleted
-
Lumenis Be Ltd.Completed
-
Aier School of Ophthalmology, Central South UniversityUnknown
-
Samsung Medical CenterWithdrawnDry Eye SyndromesKorea, Republic of